Skip to main content
Log in

Reply to the letter to the editors

  • Letter to the Editors/Reply
  • Quercetin, P-glycoprotein, CYP3A Isozymes
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Cushman M, Nagarathnam D, Burg DL, Geahlen RL (1991) Synthesis and protein-tyrosine kinase inhibitory activities of flavonoid analogue. J Med Chem 34:798–806

    Google Scholar 

  2. Havsteen B (1983) Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 32:1141–1148

    Google Scholar 

  3. Nakadate T, Yamamoto S, Aizu E, Kato R (1984) Effects of flavonoids and antixidants on 12-O-tetradecanoylphorbol-13-acetate caused epidermal ornithine decarboxilase induction and tumour promotion in relation to lipoxigenase inhibition by these compounds. Jpn J Cancer Res 75:214

    Google Scholar 

  4. Vlietink AJ, Vanden Berghe DA, Haemers A (1988) In: Cody V, Middleton E Jr, Harbone JB, Beretz A (eds) Plant flavonoids in biology and medicine, vol II. Biochemical, cellular, and medicinal properties. Alan R. Liss, New York, pp 283–299

    Google Scholar 

  5. Minisalco A, Lundahl J, Regardh CG, Edgar B, Erisksson UG (1992) Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice. J Pharmacol Exp Ther 261:1195–1199

    Google Scholar 

  6. Bailey DG, Spence JD, Munoz C, Arnold JMO (1991) Interaction of citrus juices with felodopine and nifedipine. Lancet 337:268

    Google Scholar 

  7. Gandhi RK, Khanduja KL (1993) Impact of quercetin consumption on phase I and phase II drug-metabolizing enzymes in mice. J Clin Biochem Nutr 14:107–112

    Google Scholar 

  8. Scambia G, Ranelletti FO, Panici PB, De Vincenzo R, Bonanno G, Ferrandina G, Piantelli M, Bussa S, Rumi C, Cianfriglia M, Mancuso S (1994) Quercetin potentiates the effect of Adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemother Pharmacol 34:459–464

    Google Scholar 

  9. Gugler R, Leschik M, Dengler HJ (1975) Disposition of quercetin in man after single oral intravenous doses. Eur J Clin Pharmacol 9: 229–234

    Google Scholar 

  10. Buzzelli G, Moscarella S, Giusti A, Duchini A, Marena C, Lampertico M (1993) A pilot study on the liver protective effect of silybin-phosphatidylcholine complex (IdB1016) in chronic active hepatitis. J Clin Pharmacol 31:456–460

    Google Scholar 

  11. Elangovan V, Sekar N, Govindasamy S (1994) Chemopreventive potential of dietary bioflavonoids against 20-methylcholanthrene-induced tumorigenesis. Cancer Lett 87:107–113

    Google Scholar 

  12. Verma AK, Johnson JA, Gould MN, Tanner MA (1988) Inhibition of 7,12-dimehtylbenz(a)anthracene- andN-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin. Cancer Res 48:5754–5758

    Google Scholar 

  13. Hofmann J, Fiebig HH, Winterhalter BR, Berger DP, Grunicke H (1990) Enhancement of the antiproliferative activity ofcis-diaminedichloroplatinum(II) by quercetin. Int J Cancer 45:536–539

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scambia, G., Ranelletti, F.O., Benedetti-Panici, P. et al. Reply to the letter to the editors. Cancer Chemother. Pharmacol. 36, 449–450 (1995). https://doi.org/10.1007/BF00686196

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00686196

Keywords

Navigation